Ganirelix Acetate Patent Expiration
Ganirelix Acetate is Used for preventing premature LH surges in women undergoing controlled ovarian hyperstimulation with FSH. It was first introduced by Organon Usa Llc A Sub Of Organon And Co
Ganirelix Acetate Patents
Given below is the list of patents protecting Ganirelix Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ganirelix Acetate | US6653286 | Gonadotropin releasing hormone antagonist |
Jun 16, 2018
(Expired) | Organon Usa Organon |
| Ganirelix Acetate | US5767082 | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
Jun 16, 2015
(Expired) | Organon Usa Organon |
Ganirelix Acetate's Family Patents
Explore Our Curated Drug Screens
Ganirelix Acetate Generic API Manufacturers
Several generic applications have been filed for Ganirelix Acetate. The first generic version for Ganirelix Acetate was by Sun Pharmaceutical Industries Ltd and was approved on Nov 30, 2018. And the latest generic version is by Lupin Ltd and was approved on Nov 16, 2023.
Given below is the list of companies who have filed for Ganirelix Acetate generic, along with the locations of their manufacturing plants worldwide.
1. AMPHASTAR PHARMS INC
Amphastar Pharmaceuticals Inc has filed for 1 generic for Ganirelix Acetate. Given below are the details of the strengths of this generic introduced by Amphastar Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MCG/0.5ML | injectable | Prescription | INJECTION | AP | Apr 7, 2022 |
2. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Ganirelix Acetate. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MCG/0.5ML | injectable | Prescription | INJECTION | AP | Feb 28, 2023 |
3. LUPIN LTD
Lupin Ltd has filed for 1 generic for Ganirelix Acetate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MCG/0.5ML | injectable | Prescription | INJECTION | AP | Nov 16, 2023 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
4. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Ganirelix Acetate. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MCG/0.5ML | injectable | Prescription | INJECTION | AP | Jun 6, 2022 |
5. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Ganirelix Acetate. This 250mcg/0.5ml version comes by the name FYREMADEL. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MCG/0.5ML | injectable | Prescription | INJECTION | AP | Nov 30, 2018 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||